Lynx1 Capital Management Lp Top Holdings and 13F Report (2024)

About Lynx1 Capital Management Lp

Lynx1 Capital Management Lp has $2.44 million in total holdings as of March 31, 2024.
Lynx1 Capital Management Lp owns shares of 1 different stock, but just 1 company or ETF makes up 80% of its holdings.
Approximately 100.00% of the portfolio was purchased this quarter.
About 10,439.98% of the portfolio was sold this quarter.
This quarter, Lynx1 Capital Management Lp has purchased 15 new stocks and bought additional shares in 0 stocks.
Lynx1 Capital Management Lp sold shares of 0 stocks and completely divested from 15 stocks this quarter.

Selling

Neutral

Buying

Issuer Name	Holdings Value	Approximate Purchase/Sale	Change in Shares	Shares Held	% of Portfolio	Sector
IBIO	$2,436,000	$2,436,000 ▲	New Holding	600,000	100.0%	CON NEW
ALPN Alpine Immune Sciences	$0	$72,693,429 ▼	-100.0%	0	0.0%	Medical
CABA Cabaletta Bio	$0	$47,906,103 ▼	-100.0%	0	0.0%	Medical
MRUS Merus	$0	$31,218,688 ▼	-100.0%	0	0.0%	Medical
TCRX TScan Therapeutics	$0	$30,459,418 ▼	-100.0%	0	0.0%	Medical
CCCC C4 Therapeutics	$0	$17,709,337 ▼	-100.0%	0	0.0%	Medical
STOK Stoke Therapeutics	$0	$15,553,389 ▼	-100.0%	0	0.0%	Medical
AUTL Autolus Therapeutics	$0	$11,968,154 ▼	-100.0%	0	0.0%	Medical
GHRS GH Research	$0	$10,663,979 ▼	-100.0%	0	0.0%	Medical
KNTE Kinnate Biopharma	$0	$4,732,904 ▼	-100.0%	0	0.0%	Medical
SLN Silence Therapeutics	$0	$4,095,620 ▼	-100.0%	0	0.0%	Medical
THRX Theseus Pharmaceuticals	$0	$2,844,781 ▼	-100.0%	0	0.0%	Medical
PIRS Pieris Pharmaceuticals	$0	$1,779,205 ▼	-100.0%	0	0.0%	Medical
BNOX Bionomics	$0	$1,219,971 ▼	-100.0%	0	0.0%	Medical
NKTR Nektar Therapeutics	$0	$1,089,997 ▼	-100.0%	0	0.0%	Medical
PASG Passage Bio	$0	$382,951 ▼	-100.0%	0	0.0%	Medical